Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort

Background: There is limited data available regarding safety profile of artemisinins in early pregnancy. They are, therefore, not recommended by WHO as a first-line treatment for malaria in first trimester due to associated embryo-foetal toxicity in animal studies. The study assessed birth outcome a...

Full description

Bibliographic Details
Main Author: Mosha, Dominic (author)
Other Authors: Mazuguni, Festo (author), Mrema, Sigilbert (author), Sevene, Esperança (author), Abdulla, Salim (author), Genton, Blaise (author)
Format: article
Language:eng
Published: 2021
Subjects:
Pregnancy
Safety
Artemether-lumefantrine
Exposure
Maternal health
Online Access:https://doi.org/Mosha, D., Mazuguni, F., Mrema, S. et al. Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort. Malar J 13, 197 (2014). https://doi.org/10.1186/1475-2875-13-197
Country:Mozambique
Oai:oai:www.repositorio.uem.mz:258/182

Internet

https://doi.org/Mosha, D., Mazuguni, F., Mrema, S. et al. Safety of artemether-lumefantrine exposure in first trimester of pregnancy: an observational cohort. Malar J 13, 197 (2014). https://doi.org/10.1186/1475-2875-13-197

Similar Items